Improved methods for the study of drug effects on purine metabolism and their application to nebularine and 7-deazanebularine.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D002250:Carbon Radioisotopes; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology / Q000378:metabolism; D002478:Cells, Cultured; D002848:Chromatography, DEAE-Cellulose; D011756:Diphosphates / Q000378:metabolism; D005347:Fibroblasts / Q000201:enzymology; D006147:Guanine / Q000378:metabolism; D007042:Hypoxanthines / Q000378:metabolism; D007288:Inosine; D007700:Kinetics; D009711:Nucleotides / Q000378:metabolism; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011684:Purine Nucleosides / Q000494:pharmacology*; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D012263:Ribonucleosides / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D002250:Carbon Radioisotopes; D011756:Diphosphates; D007042:Hypoxanthines; D009711:Nucleotides; D011684:Purine Nucleosides; D011687:Purines; D011743:Pyrimidines; D011758:Pyrroles; D012263:Ribonucleosides; D007288:Inosine; D006147:Guanine; D010088:Oxidoreductases; D000225:Adenine